{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:40:03Z","timestamp":1744249203676,"version":"3.40.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04095-7","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:40:51Z","timestamp":1744213251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary central nervous system tumors in patients with multiple sclerosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Masih","family":"Sabouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Dehghani Firoozabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setayesh","family":"Sindarreh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Akhavan-Sigari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"9","key":"4095_CR1","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1007\/s10072-022-06142-4","volume":"43","author":"Y Yalachkov","year":"2022","unstructured":"Yalachkov Y, Dabanli D, Wenger KJ, Forster MT, Steinbach JP, Voss M. Concurrent CNS tumors and multiple sclerosis: retrospective single-center cohort study and lessons for the clinical management. Neurol Sci. 2022;43(9):5513\u201322. https:\/\/doi.org\/10.1007\/s10072-022-06142-4","journal-title":"Neurol Sci"},{"issue":"13","key":"4095_CR2","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","volume":"72","author":"S Bahmanyar","year":"2009","unstructured":"Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Cancer risk among patients with multiple sclerosis and their parents. Neurology. 2009;72(13):1170\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000345366.10455.62","journal-title":"Neurology"},{"issue":"12","key":"4095_CR3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1177\/1352458510379244","volume":"16","author":"ML Sumelahti","year":"2010","unstructured":"Sumelahti ML, Hakama M, Elovaara I, Pukkala E. Causes of death among patients with multiple sclerosis. Mult Scler J. 2010;16(12):1437\u201342.","journal-title":"Mult Scler J"},{"issue":"6","key":"4095_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1177\/13524585211003476","volume":"27","author":"A Achiron","year":"2021","unstructured":"Achiron A, Dolev M, Menascu S, et al. COVID-19 vaccination in patients with multiple sclerosis: what we have learnt by February 2021. Mult Scler J. 2021;27(6):864\u201370. https:\/\/doi.org\/10.1177\/13524585211003476","journal-title":"Mult Scler J"},{"issue":"4","key":"4095_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ijc.21437","volume":"118","author":"NM Nielsen","year":"2006","unstructured":"Nielsen NM, Rostgaard K, Rasmussen S, et al. Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer. 2006;118(4):979\u201384.","journal-title":"Int J Cancer"},{"issue":"7","key":"4095_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/WNL.0b013e3181c777b7","volume":"74","author":"S Hofer","year":"2010","unstructured":"Hofer S, Linnebank M, Weller M. Cancer risk among patients with multiple sclerosis and their parents. Neurology. 2010;74(7):614\u20135.","journal-title":"Neurology"},{"issue":"2","key":"4095_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1352458517751049","volume":"24","author":"X Montalban","year":"2018","unstructured":"Montalban X, Gold R, Thompson AJ, et al. ECTRIMS\/EAN guideline on the Pharmacological treatment of people with multiple sclerosis. Mult Scler J. 2018;24(2):96\u2013120.","journal-title":"Mult Scler J"},{"issue":"6","key":"4095_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl). 2016;131(6):803\u201320.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"4095_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.12267","volume":"21","author":"L Sun","year":"2014","unstructured":"Sun L, Lin C, Chung C, Liang J, Sung F, Kao C. Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study. Eur J Neurol. 2014;21(2):238\u201344.","journal-title":"Eur J Neurol"},{"issue":"2","key":"4095_CR10","first-page":"30","volume":"25","author":"AH Sirko","year":"2020","unstructured":"Sirko AH, Dzyak LA, Chekha EV. Coexistence of multiple sclerosis and brain tumors: a literature review. \u041c\u0435\u0434\u0438\u0447\u043d\u0456 \u041f\u0435\u0440\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u0438. 2020;25(2):30\u20136.","journal-title":"\u041c\u0435\u0434\u0438\u0447\u043d\u0456 \u041f\u0435\u0440\u0441\u043f\u0435\u043a\u0442\u0438\u0432\u0438"},{"issue":"6","key":"4095_CR11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/neuonc\/nop066","volume":"12","author":"KR Porter","year":"2010","unstructured":"Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG. Prevalence estimates for primary brain tumors in the united States by age, gender, behavior, and histology. Neuro-Oncol. 2010;12(6):520\u20137.","journal-title":"Neuro-Oncol"},{"issue":"S7","key":"4095_CR12","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/cncr.23741","volume":"113","author":"ML Bondy","year":"2008","unstructured":"Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer. 2008;113(S7):1953\u201368.","journal-title":"Cancer"},{"issue":"6","key":"4095_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/neuonc\/nou283","volume":"17","author":"P de Robles","year":"2015","unstructured":"de Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro-Oncol. 2015;17(6):776\u201383.","journal-title":"Neuro-Oncol"},{"key":"4095_CR14","unstructured":"Farmanfarma KHK, Mohammadian M, Shahabinia Z, Hassanipour S, Salehiniya H. Brain cancer in the world: an epidemiological review. World Cancer Res J. 2019;6(5)."},{"issue":"Supplement3","key":"4095_CR15","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2014\u20132018. Neuro-Oncol. 2021;23(Supplement3):iii1\u2013105.","journal-title":"Neuro-Oncol"},{"issue":"11","key":"4095_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/cancers10110431","volume":"10","author":"R Torensma","year":"2018","unstructured":"Torensma R. The dilemma of cure and damage in oligodendroglioma: ways to tip the balance away from the damage. Cancers. 2018;10(11):431.","journal-title":"Cancers"},{"issue":"9","key":"4095_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","volume":"4","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the united States from 2000 to 2014. JAMA Oncol. 2018;4(9):1254\u201362.","journal-title":"JAMA Oncol"},{"issue":"12","key":"4095_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1024\/0040-5930\/a000230","volume":"68","author":"F Stucker","year":"2011","unstructured":"Stucker F, Ackermann D. Immunosuppressive drugs-how they work, their side effects and interactions. Ther Umsch Rev Ther. 2011;68(12):679\u201386.","journal-title":"Ther Umsch Rev Ther"},{"issue":"5","key":"4095_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr TA, Shen P, Brown S, et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6\u2013producing B cells. J Exp Med. 2012;209(5):1001\u201310.","journal-title":"J Exp Med"},{"issue":"10","key":"4095_CR20","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","volume":"178","author":"M Duddy","year":"2007","unstructured":"Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and Naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007;178(10):6092\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"4095_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.imbio.2016.09.009","volume":"222","author":"J Shen","year":"2017","unstructured":"Shen J, Wu S, Guo W, Liang S, Li X, Yang X. Epigenetic regulation of pro-inflammatory cytokine genes in lipopolysaccharide-stimulated peripheral blood mononuclear cells from broilers. Immunobiology. 2017;222(2):308\u201315.","journal-title":"Immunobiology"},{"issue":"10","key":"4095_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/cells8101143","volume":"8","author":"GS Markopoulos","year":"2019","unstructured":"Markopoulos GS, Roupakia E, Marcu KB, Kolettas E. Epigenetic regulation of inflammatory cytokine-induced epithelial-to-mesenchymal cell transition and cancer stem cell generation. Cells. 2019;8(10):1143.","journal-title":"Cells"},{"key":"4095_CR23","doi-asserted-by":"crossref","unstructured":"Shanmugam MK, Sethi G. Role of epigenetics in inflammation-associated diseases. Epigenetics Dev Dis Published Online 2013;627\u201357.","DOI":"10.1007\/978-94-007-4525-4_27"},{"issue":"23","key":"4095_CR24","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3748\/wjg.v25.i23.2863","volume":"25","author":"ZH Yang","year":"2019","unstructured":"Yang ZH, Dang YQ, Ji G. Role of epigenetics in transformation of inflammation into colorectal cancer. World J Gastroenterol. 2019;25(23):2863.","journal-title":"World J Gastroenterol"},{"key":"4095_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fmolb.2020.00063","volume":"7","author":"JP Vernot","year":"2020","unstructured":"Vernot JP. Senescence-associated pro-inflammatory cytokines and tumor cell plasticity. Front Mol Biosci. 2020;7:63.","journal-title":"Front Mol Biosci"},{"issue":"5","key":"4095_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3322\/canjclin.38.5.258","volume":"38","author":"D Goldstein","year":"1988","unstructured":"Goldstein D, Laszlo J. The role of interferon in cancer therapy: a current perspective. CA Cancer J Clin. 1988;38(5):258\u201377.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4095_CR27","first-page":"970315","volume":"2014","author":"R Asmana Ningrum","year":"2014","unstructured":"Asmana Ningrum R. Human interferon alpha-2b: a therapeutic protein for cancer treatment. Scientifica. 2014;2014(1):970315.","journal-title":"Scientifica"},{"issue":"1","key":"4095_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-004-0549-1","volume":"54","author":"P Tagliaferri","year":"2005","unstructured":"Tagliaferri P, Caraglia M, Budillon A, et al. New Pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-\u03b1) treatment of human cancer. Cancer Immunol Immunother. 2005;54(1):1\u201310. https:\/\/doi.org\/10.1007\/s00262-004-0549-1","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"4095_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/00002018-199410020-00003","volume":"10","author":"T Vial","year":"1994","unstructured":"Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf. 1994;10(2):115\u201350.","journal-title":"Drug Saf"},{"issue":"s 6","key":"4095_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/1523-1747.ep12874776","volume":"95","author":"I Gresser","year":"1990","unstructured":"Gresser I. Biologic effects of interferons. J Invest Dermatol. 1990;95(s 6):66\u201371.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"4095_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00234-005-1392-6","volume":"47","author":"A Drevelegas","year":"2005","unstructured":"Drevelegas A, Xinou E, Karacostas D, Parissis D, Karkavelas G, Milonas I. Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship? Neuroradiology. 2005;47(7):516\u20139.","journal-title":"Neuroradiology"},{"key":"4095_CR32","doi-asserted-by":"crossref","unstructured":"Gopakumar S, Daou M, Gadot R, Ropper AE, Mandel J. Spinal meningioma in a patient with multiple sclerosis. Surg Neurol Int. 2020;11.","DOI":"10.25259\/SNI_221_2020"},{"issue":"1\u20132","key":"4095_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1081\/ERC-120004533","volume":"28","author":"C Heesen","year":"2002","unstructured":"Heesen C, Gold SM, Bruhn M, M\u00f6nch A, Schulz KH. Prolactin stimulation in multiple sclerosis\u2013an indicator of disease subtypes and activity? Endocr Res. 2002;28(1\u20132):9\u201318.","journal-title":"Endocr Res"},{"issue":"3","key":"4095_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11060-009-0076-1","volume":"98","author":"V Nociti","year":"2010","unstructured":"Nociti V, Frisullo G, Tartaglione T, et al. Multiple sclerosis attacks triggered by hyperprolactinemia. J Neurooncol. 2010;98(3):407\u20139.","journal-title":"J Neurooncol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04095-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04095-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04095-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:04:38Z","timestamp":1744247078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04095-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4095"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04095-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Isfahan University of Medical Sciences ethical committee (IR.MUI.MED.REC.1399.900) and proper informed consent was taken from patients for participation in our study. This study was conducted in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}